Cancer Channel
Related Channels

Bevacizumab Dosing

Bevacizumab Dosing for Lung Cancer

The recommended dose of bevacizumab when treating non-squamous, non-small cell lung cancer is 15 mg per kg (about 6.8 mg per pound) given by IV every three weeks.

Bevacizumab Dosage for Breast Cancer, Brain Cancer, or Kidney Cancer

The recommended dose of bevacizumab when treating breast cancer, glioblastoma (a type of brain cancer), or renal cell cancer (a type of kidney cancer) is 10 mg per kg (about 4.5 mg per pound) given by IV every 14 days.

General Information on Dosing With Bevacizumab

Considerations for people taking bevacizumab include the following:
  • The medication is given by IV, usually at a hospital or cancer clinic.
  • Your first bevacizumab dose should be given slowly, over 90 minutes. If you tolerate it well, your next dose can be given over 60 minutes. If you tolerate that dose well, your next dose (and any future doses) can be given over 30 minutes.
  • Bevacizumab should be stopped several weeks before major surgery and should not be started again until at least 28 days after surgery and until the surgical wound has fully healed.
  • You can receive your bevacizumab infusion with or without food. However, your healthcare provider may have specific reasons for preferring one over the other, so be sure to ask him or her if your stomach should be empty or full when receiving the drug.
  • For the medication to work properly, it must be taken as prescribed. Bevacizumab will not work if you stop taking it.
  • If you are unsure about anything related to bevacizumab or bevacizumab dosing in general, talk to your doctor, nurse, or pharmacist. Do not stop taking the drug without first discussing it with your healthcare provider.
7 Natural Ways to Reduce Your Cancer Pain

Bevacizumab for Cancer Treatment

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.